Physician profile
Lauren Laino
NPI 1982369187
$1,095.39
in general payments reported to CMS, 2019-2025
10 companies · $251 in 2025
The $251 reported for 2025 was more than what 79% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $527 · 2023: $172 · 2024: $145 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $278.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $248.93 | 2022 | |
| Abbvie INC. | $127.06 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2023 | Austedo |
| Otsuka America Pharmaceutical, INC. | $124.99 | 2024 | Rexulti |
| Exact Sciences Corporation | $124.19 | 2025 | The Cologuard Plus Collection Kit |
| Galderma Laboratories, L.P. | $19.82 | 2024 | |
| Corium, LLC | $17.68 | 2023 | Adlarity |
| Sumitomo Pharma America, INC. | $15.37 | 2023 | Gemtesa |
| Lilly USA, LLC | $14.22 | 2023 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Laino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.